PHASE I TRIAL OF DNX-2401 ONCOLYTIC ADENOVIRUS COMBINED WITH A SHORT COURSE OF DOSE-DENSE TEMOZOLOMIDE FOR RECURRENT GLIOBLASTOMA

被引：0
|
作者：
Perez-Larraya, J. Gallego [1 ]
Garcia-Moure, M. [2 ]
Gonzalez-Huarriz, M. [2 ]
Zalacain, M. [2 ]
Marrodan, L. [2 ]
Puigdelloses, M. [2 ]
Labiano, S.
de la Nava, D. [2 ]
Laspidea, V. [2 ,3 ]
Ausejo, I. [2 ]
Hervas, I. [2 ]
Esparragosa, I. [1 ]
Giraldez, M. [1 ]
Dominguez, P. [1 ]
Martinez-Simon, A. [1 ]
Idoate, M. [1 ]
Fueyo, J. [4 ]
Gomez-Manzano, C. [4 ]
Patino, A. [1 ]
Diez-Valle, R. [5 ]
Tejada, S. [5 ]
Alonso, M.
机构：
[1] Clin Univ Navarra, Pamplona, Spain
[2] Ctr Appl Med Res, Pamplona, Spain
[3] Univ Navarra, Pamplona, Spain
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[5] Quiron Hosp, Madrid, Spain
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
10.1093/neuonc/noad137.404
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P17.14.B
引用
收藏
页码：120 / 120
页数：1
相关论文
共 50 条
  • [31] NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma
    Gilbert, Mark R.
    Pugh, Stephanie L.
    Aldape, Ken
    Sorensen, A. Gregory
    Mikkelsen, Tom
    Penas-Prado, Marta
    Bokstein, Felix
    Kwok, Young
    Lee, R. Jeffrey
    Mehta, Minesh
    JOURNAL OF NEURO-ONCOLOGY, 2017, 131 (01) : 193 - 199
  • [32] FIRST-IN-HUMAN PHASE I CLINICAL TRIAL OF ONCOLYTIC DELTA-24-RGD (DNX-2401) WITH BIOLOGICAL ENDPOINTS: IMPLICATIONS FOR VIRO-IMMUNOTHERAPY
    Lang, Frederick F.
    Conrad, Charles
    Gomez-Manzano, Cande
    Tufaro, Frank
    Yung, W. K. A.
    Sawaya, Raymond
    Weinberg, Jeffrey
    Prabhu, Sujit
    Fuller, Gregory
    Aldape, Kenneth
    Fueyo, Juan
    NEURO-ONCOLOGY, 2014, 16
  • [33] RTOG 0625: A RANDOMIZED PHASE II TRIAL OF BEVACIZUMAB WITH EITHER IRINOTECAN (CPT) OR DOSE-DENSE TEMOZOLOMIDE (TMZ) IN RECURRENT GLIOBLASTOMA (GBM)
    Gilbert, Mark R.
    Wang, Meihua
    Aldape, Kern
    Sorensen, A. Gregory
    Mikkelsen, Tom
    Bokstein, Felix
    Woo, Shaio Y.
    Chmura, Steven J.
    Choucair, Ali K.
    Mehta, Minesh
    NEURO-ONCOLOGY, 2010, 12 : 39 - 39
  • [34] PHASE II STUDY OF BEVACIZUMAB IN COMBINATION WITH DOSE-DENSE TEMOZOLOMIDE IN PATIENTS WITH RECURRENT GLIOBLASTOMA: PRELIMINARY SAFETY ANALYSIS
    Sepulveda, Juan
    Belda, Cristobal
    Balana, Carmen
    Perez Segura, Pedro
    Reynes, Gaspar
    Gil, Miquel
    Gallego, Oscar
    Berrocal, Alfonso
    NEURO-ONCOLOGY, 2011, 13 : 55 - 55
  • [35] THANK PHASE I TRIAL OF DNX-2440 ONCOLYTIC ADENOVIRUS IN PATIENTS WITH FIRST OR SECOND RECURRENCE OF GLIOBLASTOMA: PRELIMINARY RESULTS
    Perez-Larraya, J. Gallego
    de la Nava, D.
    Gonzalez-Huarriz, M.
    Garcia-Moure, M.
    Labiano, S.
    Zalacain, M.
    Marrodan, L.
    Ausejo, I.
    Laspidea, V.
    Hervas, I.
    Puigdelloses, M.
    Esparragosa, I.
    Giraldez, M.
    Serrano, M.
    Dominguez, P.
    Diez-Valle, R.
    Fueyo, J.
    Gomez-Manzano, C.
    Patino, A.
    Tejada, S.
    Bejarano, B.
    Alonso, M.
    NEURO-ONCOLOGY, 2023, 25
  • [36] Randomized Phase II Trial of Chemoradiotherapy Followed by Either Dose-Dense or Metronomic Temozolomide for Newly Diagnosed Glioblastoma
    Clarke, Jennifer L.
    Iwamoto, Fabio M.
    Sul, Joohee
    Panageas, Katherine
    Lassman, Andrew B.
    DeAngelis, Lisa M.
    Hormigo, Adilia
    Nolan, Craig P.
    Gavrilovic, Igor
    Karimi, Sasan
    Abrey, Lauren E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (23) : 3861 - 3867
  • [37] A phase I clinical trial of sonodynamic therapy combined with temozolomide in the treatment of recurrent glioblastoma
    Boya Zha
    Junping Yang
    Qianqian Dang
    Peihong Li
    Shuling Shi
    Jingjing Wu
    Haiyang Cui
    Linkuan Huangfu
    Yuxin Li
    Daoke Yang
    Yingjuan Zheng
    Journal of Neuro-Oncology, 2023, 162 : 317 - 326
  • [38] A phase I clinical trial of sonodynamic therapy combined with temozolomide in the treatment of recurrent glioblastoma
    Zha, Boya
    Yang, Junping
    Dang, Qianqian
    Li, Peihong
    Shi, Shuling
    Wu, Jingjing
    Cui, Haiyang
    Huangfu, Linkuan
    Li, Yuxin
    Yang, Daoke
    Zheng, Yingjuan
    JOURNAL OF NEURO-ONCOLOGY, 2023, 162 (2) : 317 - 326
  • [39] PHASE I TRIAL OF TG02 PLUS DOSE-DENSE OR METRONOMIC TEMOZOLOMIDE FOR RECURRENT HIGH-GRADE ASTROCYTOMA IN ADULTS
    Wu, Jing
    Bryla, Christine
    Su, Yu-Ting
    Grajkowska, Ewa
    McCoy, Ann
    Boris, Lisa
    Antony, Ramya
    Garren, Nancy
    Siegel, Christine
    Cordova, Christine
    Aboud, Orwa
    Vera, Elizabeth
    Lawhon, Tracy
    Penas-Prado, Marta
    Theeler, Brett
    Mendoza, Tito
    Armstrong, Terri
    Yuan, Ying
    Gilbert, Mark
    NEURO-ONCOLOGY, 2019, 21 : 27 - 28
  • [40] A PHASE II STUDY OF LAPATINIB AND DOSE-DENSE TEMOZOLOMIDE (TMZ) FOR ADULTS WITH RECURRENT EPENDYMOMA: A CERN CLINICAL TRIAL
    Gilbert, Mark
    Yuan, Ying
    Wani, Khalida
    Wu, Jimin
    Omuro, Antonio
    Lieberman, Frank
    Robins, H. Ian
    Gerstner, Elizabeth
    Wu, Jing
    Wen, Patrick
    Mikkelsen, Tom
    Armstrong, Terri
    Aldape, Ken
    NEURO-ONCOLOGY, 2014, 16
12345